7 February 2026
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
21 January 2026
Spotlight’s 2026 Healthcare Watchlist highlights nine health topics, from a new HIV prevention jab to NHI court battles and aid shocks.
9 January 2026
HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
7 January 2026
South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.
24 November 2025
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
5 November 2025
Lenacapavir has been registered by SAHPRA as an innovative HIV prevention injection. Find out more about its rollout in South Africa.
16 October 2025
South Africa receives a significant R2 billion HIV funding boost from the US CDC to sustain crucial health initiatives.
16 October 2025
Understand how African philanthropists can lead the way in health improvement efforts, saving lives and supporting innovation.
29 September 2025
Explore the benefits of the generic HIV prevention drug lenacapavir, set to change the landscape of global health by 2027.
4 September 2025
Discover the new HIV prevention injection coming to South Africa. Learn how lenacapavir offers a game-changing alternative to daily pills.
3 September 2025
Discover the new HIV prevention injection coming to South Africa. Learn how lenacapavir offers a game-changing alternative to daily pills.
28 August 2025
Learn about Sakeliga's NHI legal battle as they challenge the constitutionality of South Africa's National Health Insurance plan.